Evidence map›Paper›PMID 40143106›Full record

ReviewPharmaceuticals (Basel, Switzerland)2025

Ghosoon Albahri, Adnan Badran, Zaher Abdel Baki, Mohamad Alame, Akram Hijazi, Anis Daou, Joelle Edward Mesmar, Elias Baydoun

Abstract readReview
In one paragraph

Review in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Anti-Inflammatory Activity ofPharmaceuticals (Basel, Switzerland) · 2026
    Article
  3. International journal of molecular sciences · 2025
    Article
  4. Green Synthesis of Gold Nanoparticles UsingPharmaceuticals (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ghosoon AlbahriDoctoral School of Science and Technology-Platform of Research and Analysis in Environmental Sciences (EDST-PRASE), Beirut P.O. Box 657314, Lebanon.ORCID 0000-0003-4489-6606
Adnan BadranDepartment of Nutrition, University of Petra Amman Jordan, Amman P.O. Box 961343, Jordan.
Zaher Abdel BakiCollege of Engineering and Technology, American University of the Middle East, Egaila 54200, Kuwait.ORCID 0000-0002-2070-5855
Mohamad AlameDoctoral School of Science and Technology-Platform of Research and Analysis in Environmental Sciences (EDST-PRASE), Beirut P.O. Box 657314, Lebanon.
Akram HijaziDoctoral School of Science and Technology-Platform of Research and Analysis in Environmental Sciences (EDST-PRASE), Beirut P.O. Box 657314, Lebanon.ORCID 0000-0003-4984-8531
Anis DaouPharmaceutical Sciences Department, College of Pharmacy, QU Health, Qatar University, Doha P.O. Box 2713, Qatar.ORCID 0000-0001-8495-3076
Joelle Edward MesmarDepartment of Biology, Faculty of Arts and Sciences, American University of Beirut, Riad El Solh, Beirut 1107, Lebanon.ORCID 0009-0004-7193-8079
Elias BaydounDepartment of Biology, Faculty of Arts and Sciences, American University of Beirut, Riad El Solh, Beirut 1107, Lebanon.ORCID 0000-0002-5632-1175

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the Mediterranean and Himalayan regions, the genus

Indexed as

anticancer activityantidiabeticanti-enzymaticantimicrobial activityantioxidant activityMandragora autumnalisphytochemistrytoxicological activities

Identifiers

PMID40143106
PMCPMC11944648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.